4//SEC Filing
Galletta Christopher 4
Accession 0001209191-23-010202
CIK 0001563880other
Filed
Feb 15, 7:00 PM ET
Accepted
Feb 16, 5:34 PM ET
Size
5.5 KB
Accession
0001209191-23-010202
Insider Transaction Report
Form 4
Galletta Christopher
See Remarks
Transactions
- Award
Stock Option (right to buy)
2023-02-16+40,000→ 40,000 totalExercise: $2.67Exp: 2033-02-15→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]This option was granted on February 16, 2023. The 40,000 shares of common stock underlying the option are scheduled to vest as to 25% of the shares on February 16, 2024 and as to the remaining 75% of the shares in equal monthly installments thereafter through February 16, 2027.
Documents
Issuer
Trevi Therapeutics, Inc.
CIK 0001563880
Entity typeother
Related Parties
1- filerCIK 0001486099
Filing Metadata
- Form type
- 4
- Filed
- Feb 15, 7:00 PM ET
- Accepted
- Feb 16, 5:34 PM ET
- Size
- 5.5 KB